Articles From: Evoke Pharma Announces the Completion of Enrollment in Its Thorough ECG Study for EVK-001 to ENZYMOTEC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Enzymotec Ltd. -- ENZY


SOLANA BEACH, Calif., Sept.
Sign-up for Evoke Pharma Announces the Completion of Enrollment in Its Thorough ECG Study for EVK-001 investment picks
DAVIS, Calif., Sept.
Sign-up for Scott Peoples Joins Marrone Bio Innovations as Vice President of Marketing investment picks
TAMPA, Fla., Sept.
Sign-up for "Don Diego" Project Achieves Important Milestone investment picks
SACRAMENTO, Calif., Sept.
Sign-up for Pacific Ethanol to Participate in Four September Conferences investment picks
NRG Energy has entered into an agreement to purchase FCE's previously announced 1.4 megawatt fuel cell power plant project at University of Bridgeport NRG Energy will acquire long-term power purchase agreement for clean and efficient distributed power generation with predictable cash flows DANBURY, Conn., Sept.
Sign-up for FuelCell Energy Announces Agreement to Sell University Fuel Cell Project to NRG Energy investment picks
CAMBRIDGE, Mass., Sept.
Sign-up for Aegerion Pharmaceuticals Grants Stock Options Under Inducement Program investment picks
NEW YORK, Sept.
Sign-up for ITG Releases August 2014 U.S. Trading Volumes investment picks
REDWOOD CITY, Calif., Sept.
Sign-up for Relypsa Announces Commercial Manufacturing Agreement With Patheon, Inc. investment picks
LONGMONT, Colo., Sept.
Sign-up for Dot Hill Innovation Improves Storage Performance in SAS Environments investment picks
Second quarter net sales increased 9% to $97.3 million Second quarter comparable sales decreased 7% Second quarter diluted earnings per share were $0.24 Opened 75 new boutiques through the end of the second quarter HOUSTON, Sept.
Sign-up for francesca's(R) Reports Second Quarter Fiscal Year 2014 Financial Results investment picks
WAKEFIELD, Mass., Sept.
Sign-up for Comverse Announces Fiscal 2014 Second Quarter Results; Conference Call to be Held Today at 8:00 AM investment picks
EMERYVILLE, Calif and SAO PAULO, Brazil and CLERMONT-FERRAND, France, Sept.
Sign-up for Braskem Joins Amyris and Michelin to Accelerate the Industrialization and Commercialization of Renewable Isoprene investment picks
2014/9/9
Net sales increased 8.4% to $170 million vs.
Sign-up for Quanex Building Products Corporation Reports Third Quarter 2014 Results investment picks
AUSTIN, Texas, Sept.
Sign-up for STI Enters Final Stage of Conductus Wire Production Equipment Assembly investment picks
NEWTON, Mass., Sept.
Sign-up for Karyopharm Announces Three Clinical Data Presentations at ESMO 2014 investment picks
Net Sales increased 9 percent to $2,447 million Operating Income improved 22 percent to $186 million Adjusted EBITDA increased 18 percent to $258 million Adjusted Net Income per diluted share increased 117 percent to $0.51 (Net Income per diluted share of $0.24) ATLANTA, Sept.
Sign-up for HD Supply Holdings, Inc. Announces Fiscal 2014 Second-Quarter Results investment picks
MIDDLETOWN, R.I., and CORK, Ireland, Sept.
Sign-up for KVH and Transas Team Up to Solve Mariners' Need for Fast and Affordable Updates to Mandatory Electronic Charts investment picks
TEL AVIV, Israel and NEW YORK, Sept.
Sign-up for Top Image Systems Settles Pending Patent Infringement Litigation With Mitek Systems investment picks
REDWOOD CITY, Calif., Sept.
Sign-up for Model N Gold Sponsor at Key Pharmaceutical, MedTech Conferences in September investment picks
CARLSBAD, Calif., Sept.
Sign-up for MaxLinear Revises Third Quarter Revenue Outlook investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Evoke Pharma Announces the Completion of Enrollment in Its Thorough ECG Study for EVK-001 to ENZYMOTEC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Enzymotec Ltd. -- ENZY
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent